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Intrapancreatic Accessory Spleen:
Findings on MR Imaging, CT, US and
Scintigraphy, and the Pathologic Analysis
Although the tail of the pancreas is the second most common site of an acces-
sory spleen, intrapancreatic accessory spleen (IPAS) has rarely been noted radi-
ologically. However, as the imaging techniques have recently advanced, IPAS
will be more frequently detected as an incidental pancreatic nodule on CT or MRI.
Because accessory spleens usually pose no clinical problems, it is important to
characterize accessory spleens as noninvasively as possible. An IPAS has simi-
lar characteristics to those of the spleen on the precontrast and contrast-
enhanced images of all the imaging modalities. In particular, inhomogeneous
enhancement of an IPAS in its early phases may be a diagnostic clue.
Superparamagnetic iron oxide (SPIO)-enhanced MRI and Levovist-enhanced
US, and the mechanisms of which are theoretically similar to that of Tc-99m
scintigraphy, can be used as alternative tools to confirm the diagnosis of IPAS.
An IPAS shows a significant signal drop similar to the spleen on the SPIO-
enhanced T2 or T2*-weighted imaging and prolonged enhancement on the
delayed hepatosplenic phase of contrast-enhanced US. We review and illustrate
the differential points between IPAS and hypervascular pancreatic tumors in this
manuscript. 
ctopic splenic tissue can be categorized as two entities: splenosis that is
due to autotransplantation of splenic tissue, and this usually happens
after splenectomy (1); and accessory spleens that are congenital foci of
healthy splenic tissue that are separate from the main body of the spleen (1). 
Accessory spleens are structurally identical to the spleen and they arise from the
failure of fusion of the splenic anlage located in the dorsal mesogastrium during the
fifth week of fetal life (1). The presence of an accessory spleen has been reported in
10% to 30% of cases in postmortem studies (2) and in 45% to 65% of patients after
splenectomy (3). The locations of accessory spleens vary, i.e., the splenic hilum, the
tail of the pancreas, the greater omentum, the splenic ligament, the small and large
intestinal mesentery, the wall of the small intestine, the female adnexa and the
scrotum in descending order of prevalence. Although intrapancreatic accessory spleen
(IPAS) has rarely been noted radiologically because the spatial resolution of conven-
tional images was too low to detect them, it is not uncommon. Indeed, in an autopsy
study of 3,000 patients, 61 (16.8%) of 364 accessory spleens were found in the
pancreatic tail (2). 
It is important to characterize accessory spleens as noninvasively as possible as they
usually pose no clinical problems and no treatment is necessary except in the following
three circumstances: first, an accessory spleen may mimic lymphadenopathy or tumors
in other abdominal organs, including the pancreas. Second, accessory spleen occasion-
ally may become symptomatic because of torsion, spontaneous rupture, hemorrhage
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Eand cyst formation. Third, all functional splenic tissue
should be removed for the treatment of hematologic
disorders such as idiopathic thrombocytopenic purpura
(ITP). However, most of the previously reported IPASs
had been diagnosed correctly after invasive surgery
because they were mistaken for pancreatic tumors such as
islet cell tumor, solid pseudopapillary tumor, hypervascu-
lar metastasis and even ductal adenocarcinoma (4, 5).
Therefore, an accurate preoperative diagnosis helps to
obviate unnecessary surgery or biopsy and it eventually
lessens the overall patient morbidity. 
Based on our experience with more than 15 patients
with IPAS, this article describes the full spectrum of
findings for IPAS on US, CT and MRI, along with the
findings of Tc-99m heat-damaged red blood cell (HDRBC)
scintigraphy or the histopathology. In addition, the points
to differentiate between IPAS and hypervascular pancre-
atic tumors will also be provided. 
Histologic Features of Intrapancreatic Accessory
Spleen
On gross examination, accessory spleens are usually
surrounded by a fibrotic capsule that separates it from the
adjacent pancreatic parenchyma (Fig. 1A). On histologic
analysis, IPAS is composed of red and white pulp that is
similar to that of the normal spleen (Fig. 1B). The red pulp
is made up of numerous vascular sinuses. Between these
sinuses lie the lymphoid follicles and the cells of the reticu-
loendothelial system (RES), which together constitute the
white pulp. The white-to-red pulp ratio increases with a
patient’s age and progressive antigenic stimulation (6). This
unique anatomy of the spleen leads to normal variations in
appearance that can be fully appreciated on CT and MRI.
Red pulp contributes to the low signal intensity (SI) of the
spleen on T2-weighted images because this pulp consists of
the sinusoids of non-thrombotic blood, whereas the white
pulp contributes to high SI on T2-weighted images because
of the higher water content of the lymphoid tissue (6).
As was the case in our study population, IPAS can have
a different white-to-red pulp ratio compared to normal
spleen even though the reason for the difference in its ratio
MRI, CT, US and Scintigraphic Findings of Intrapancreatic Accessory Spleen with Pathologic Analysis
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Fig. 1. Gross pathologic and histologic findings of intrapancreatic accessory spleen. 
A. Cross section of resected specimen of intrapancreatic accessory spleen shows reddish nodule (arrows) surrounded by yellowish
pancreatic parenchyma (P). S = main spleen
B. Photomicrographs (original magnification, Hematoxylin & Eosin staining,  100) show splenic tissue surrounded by fibrous capsule
(arrows). Note higher white (arrowheads)-to-red (*) pulp ratio in intrapancreatic accessory spleen than that in normal spleen (right lower
corner). 
AB
Fig. 2. 70-year-old man with intrapancreatic accessory spleen.
On T2-weighted turbo spin-echo image, intrapancreatic
accessory spleen (arrows) shows high signal intensity compared
to pancreas. Lesion also has slightly higher signal intensity than
spleen (S). Intrapancreatic accessory spleen was confirmed by
Tc-99m SPECT. Kim et al.
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Fig. 3. US appearance of intrapancreatic accessory spleen. 
A. Oblique coronal gray-scale US scan shows 2.4-cm size lobulated intrapancreatic accessory spleen (arrow) that is slightly hypoechoic
relative to surrounding pancreas tissue (arrowheads) and it has thin echogenic rim. Note posterior acoustic enhancement (double arrow)
behind lesion. S = spleen, LK = left kidney
B. Power Doppler US image demonstrates two vascular pedicles (arrowheads) entering into intrapancreatic accessory spleen (arrow). 
Fig. 4. Levovist-enhanced US appearance of intrapancreatic accessory spleen. On serial contrast-enhanced US images obtained 22 sec
(upper left), 40 sec (upper right), 88 sec (lower left) and 4 minutes (lower right) after contrast injection, enhancement patterns of intrapan-
creatic accessory spleen (arrow) that are similar to that of spleen are demonstrated on all four dynamic phases. Note clearly visualized
vascular pedicles (open arrows) within intrapancreatic accessory spleen on early vascular phase image (upper left) and early heteroge-
neous enhancement of lesion (arrow) on late arterial phase image (upper right). Prolonged and homogeneous enhancement of intrapan-
creatic accessory spleen on delayed hepatosplenic parenchymal phase is one of characteristic US features of intrapancreatic accessory
spleen (lower right). Intrapancreatic accessory spleen (arrow) and main spleen (S) show higher echogenicity than that of pancreas
(arrowheads) on all contrast-enhanced US phases.is unclear (Fig. 1B). This means that the SI of IPAS on T2-
weighted imaging can be different from that of the normal
spleen (7) (Fig. 2). Such higher T2 SI may be responsible
for observing a higher white-to-red pulp ratio compared to
normal spleen (7); consequently, this may lead radiologists
to make an incorrect diagnosis. Familiarity with this
histologic-radiologic correlation minimizes the chance that
the IPAS will be mistaken for pancreatic neoplasm. 
Imaging Findings of Intrapancreatic Accessory Spleen
Ultrasonography
On gray-scale baseline US, an accessory spleen is usually
seen as a round or oval mass with a mildly echogenic and
homogeneous texture and shows posterior enhancement
behind the lesion (8) (Fig. 3). Accessory spleens are usually
surrounded by a high-amplitude interface (8) that is
observed to be a fibrotic capsule on histologic examina-
tion. On color or power Doppler US, a characteristic blood
supply, that is, the presence of a vascular hilum entering
the lesion, has been reported to be a sensitive (90% of
sensitivity) diagnostic feature of accessory spleen (8) (Fig.
3). In a previous study, such a vascular hilum was observed
in three (50%) of six patients who underwent color (or
power) Doppler US imaging (9). 
In a previous study, contrast-enhanced US using
Levovist (Schering, Berlin, Germany) showed characteris-
tic enhancement features that allow the diagnosis of IPAS
(9) (Fig. 4). On the early vascular phase, one or more
vascular pedicles entering the IPAS can be more clearly
visualized than on color or power Doppler US. During
other phases of contrast enhanced-US, the IPASs showed
enhancement patterns identical to those of the spleen. On
the arterial phase, inhomogeneous enhancement related to
the different flow rate through the cords of the red and
white pulp can serve as another diagnostic feature. Most
IPASs become homogeneous on the portal venous phase,
showing dense persistent enhancement for as long as 3 to 5
minutes (Fig. 4). Such persistent enhancement of IPAS on
the hepatosplenic parenchymal phase is thought to occur
due to prolonged entrapment of Levovist by the RES cells
in the splenic tissue (9). The mechanism of Levovist-
enhanced US on the hepatosplenic phase is theoretically
similar to those of Tc-99m HDRBC scintigraphy and
MRI, CT, US and Scintigraphic Findings of Intrapancreatic Accessory Spleen with Pathologic Analysis
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Fig. 5. Typical multidetector CT appearance of intrapancreatic accessory spleen. On precontrast CT image (left upper), lesion shows iso-
attenuation compared to pancreas and spleen. On contrast-enhanced axial CT images obtained during arterial phase (right upper),
pancreatic phase (left lower), and portal venous (right lower) phase, intrapancreatic accessory spleen (arrows) is located in tail of
pancreas and it shows high attenuation compared to pancreas on all phases and it is isoattenuating compared to spleen. Note inhomo-
geneous enhancement within lesion, which is identical to zebra-striped enhancement of spleen on arterial phase (right upper).superparamagnetic iron oxide (SPIO)-enhanced MRI (7),
and these modalities are used as a confirmatory tool to
diagnose IPAS. On all dynamic US phases, the echo-
enhancement of IPAS is usually greater than that of the
pancreas (Fig. 4).
Multidetector-row CT Findings
The multidetector-row CT (MDCT) appearance of IPAS
largely depends on the CT phases that are used. In our
hospital, if a hypervascular nodule is detected in the
pancreas on single phase CT images, we usually
recommend performing triple-phase (arterial, pancreatic
and portal phases) CT for further characterization of that
nodule. The same as in normal spleen, IPAS may
demonstrate heterogeneous enhancement on the early CT
phase (usually within 70 seconds after contrast administra-
tion) because of the different rates of flow through the
cords of the red and white pulp (10). With the introduction
of MDCT scanners and the recent advances of techniques
to deliver contrast agent, this inhomogeneous enhance-
ment pattern might be more frequently observed even in
small IPASs and it can be a helpful feature to differentiate
them from other hypervascular pancreatic tumors (Fig. 5).
The attenuation of IPAS on all the dynamic CT phases is
usually similar to that of the spleen (Figs. 5, 6). In general,
because attenuation of the spleen is higher than that of the
pancreas on the arterial, pancreatic and portal venous
phases, we can easily presume that IPAS will be brighter
than the pancreas on all three dynamic CT phases. Indeed,
according to a previous study that examined seven IPASs,
the mean HU value of the IPASs was higher than that of
the pancreas on all three enhanced CT phases (7).
However, the attenuation of IPAS can, on rare occasions,
be lower than that of the pancreas on the arterial and
pancreatic phases (Fig. 6). It can occur under a condition
when splenic enhancement is retarded, such as liver cirrho-
sis (11). Indeed, one of our patients (Fig. 6) was followed-
up due to advanced liver cirrhosis. Nonetheless, the
Kim et al.
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Fig. 6. Atypical CT appearance of small intrapancreatic accessory spleen in 52-year-old man with advanced liver cirrhosis. On precon-
trast axial CT scan (left upper), lesion (arrow) shows iso-attenuation compared to pancreas. Axial CT image obtained during arterial
phase (right upper) depicts round, well-demarcated and low-attenuating nodule (arrow) in pancreas tail. However, lesion shows attenua-
tion that’s identical to spleen (S). On oblique coronal multiplanar reconstruction images obtained during pancreatic (left lower) and portal
(right lower) phases, intrapancreatic accessory spleen (arrows) shows low attenuation compared to pancreas on pancreatic phase (left
lower), iso-attenuation compared to pancreas on portal phase (right lower) and iso-attenuation compared to spleen (S) on both phases.
Even though main spleen still shows slight heterogeneity on portal phase (right lower), intrapancreatic accessory spleen can not be
distinguished from adjacent pancreas on portal phase due to its small size. Retarded splenic perfusion due to liver cirrhosis is regarded
as possible cause for such low attenuation of both spleen and intrapancreatic accessory spleen on early CT phases.attenuation of IPAS is equal to that of the spleen (Fig. 6). 
On the contrary, other hypervascular pancreatic tumors,
including islet cell tumor, were hyperattenuating on the
arterial phase and iso- or low-attenuating to the adjacent
pancreas on the venous phase (12, 13). Therefore, the
prolonged enhancement of IPAS relative to the pancreas
on the portal venous phase would provide another clue for
the diagnosis (Fig. 5).
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Fig. 8. Technetium-99m heat-damaged red blood cell SPECT of intrapancreatic accessory spleen. 
A. Coronal Tc-99m SPECT image of upper abdomen shows hot uptake foci (arrow) near splenic hilum. S = spleen, L = liver
B. Co-registered and fused image (middle) between coronal Tc-99m SPECT (right) and T2-weighted coronal MR (left) images, confirms
that SPECT hot uptake (arrows) matched corresponding high-signal intensity intrapancreatic lesion (arrowhead) seen on MRI. 
AB
AB
Fig. 7. MRI features of intrapancreatic accessory spleen. 
A. Intrapancreatic accessory spleen (arrow) shows high signal
intensity compared to pancreas (arrowheads) on axial, fat-
saturated, T2-weighted turbo spin-echo image. 
B. Lesion (arrow) shows low signal intensity compared to pancreas
(arrowheads) on axial, 2D T1-weighted gradient echo image (left
upper). Signal intensity of intrapancreatic accessory spleen is
similar to that of spleen (S). On gadolinium-enhanced MR images
obtained during arterial phase (right upper), lesion (arrows) shows
intense heterogeneous lesion enhancement. Heterogeneous
enhancement, which is characteristic of splenic tissue during early
phase (within 70 secs), is identical to that of spleen (S). This is due
to different flow rates through cords of red and white pulp. On
portal (left lower) and delayed (right lower) phases, lesion (arrows)
has become homogenously high and iso-intense relative to
surrounding pancreas parenchyma (arrowheads), respectively.
Signal intensity of lesion is exactly identical to that of spleen. 
C. Precontrast (left) and SPIO-enhanced (right) T2*-weighted
images show signal drop in intrapancreatic accessory spleen
(arrows) to similar degree compared to that of main spleen (S)
when compared to precontrast image (left).
CMRI
The MR findings of IPAS have rarely been reported (4,
7, 14). Pancreatic tumors share signal characteristics with
that of the spleen on MRI and so this accounts for the
difficulty in differentiating IPAS from pancreatic tumors. In
a previous report (7) in which we analyzed the MR
findings of seven IPASs, the SI of IPAS was darker than
that of the surrounding pancreatic parenchyma on the T1-
weighted images and it was brighter than that of the
pancreas on the T2-weighted images (Fig. 7). The key for
diagnosing IPAS is that SIs of the IPAS are identical to
those of the spleen on multiple MR pulse sequences (Fig.
7). However, we found that the SI of one IPAS was slightly
brighter than that of the spleen on the T2-weighted images
and this finding, such as the bright T2 SI, was due to the
higher white-to-red pulp ratio of the IPAS, as was
determined by pathologic examination (7) (Figs. 1, 2). 
Even though dynamic gadolinium (Gd)-enhanced MRI
has gained an important role for characterizing intrapan-
creatic lesions, any reports on dynamic MR findings of
IPAS are very rare (4, 14). As might be expected, the
enhancement of IPAS on MRI is similar to that of the
adjacent normal spleen (Fig. 7). The same as on US or CT,
the characteristic inhomogeneous enhancement of IPAS
may be seen on the arterial phase Gd-enhanced MRI (Fig.
7). However, unlike hepatic tumors, those lesions located
in the pancreas may be less conspicuous on the Gd-
enhanced MR images because of the high SI of the
pancreas on the unenhanced T1-weighted images.
Superparamagnetic iron oxide-enhanced MRI, which
theoretically uses the identical principle to that of Tc-99m
HDRBC scintigraphy, has recently been proposed as an
Kim et al.
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Table 1. Differential Points Between Intrapancreatic Accessory Spleen and Other Hypervascular Tumors on Various Imaging
Studies
Clinical and Radiologic Findings IPAS
Other Hypervascular Tumors
Islet Cell Tumor Hypervascular Metastasis
Clinical History Incidentally  Hormone-related  History of renal cell
detected symptoms if functional carcinoma
CE US AP Echogenicity to pancreas High High
Echogenicity to spleen Iso
PP or DP Prolonged, persistent  + Usually absent
enhancement 
MDCT AP Characteristic heterogeneous  + - -
enhancement (i.e., arciform)
Enhancement pattern Heterogeneous or Homogeneous or rim- Homogeneous or rim-
homogeneous  like (small size) like (small size)
Heterogeneous with  Heterogeneous with 
necrotic foci (large size) necrotic foci (large size)
PP or DP Attenuation compared to pancreas Persistently high Iso- or low Iso- or low
Attenuation compared to main spleen Iso
Calcification - Rare Rare
MRI Precontrast T1 SI to pancreas Low Low or iso Low
SI to spleen Iso
Precontrast T2 SI to pancreas High High or iso High or low (in larger lesions)
SI to spleen Usually iso
Gd-enhanced T1 Identical to dynamic CT
SPIO T2 or T2* Signal drop + - -
Mn-DPDP T1 High SI on Mn-enhanced T1 WI - +  -
Tc-99m HDRBC Scan Hot uptake + - -
Note. IPAS = intrapancreatic accessory spleen, CE US = contrast-enhanced US, AP = arterial phase, PP = portal phase, DP = delayed phase, 
Gd = gadolinium, SPIO = superparamagnetic iron oxide, Mn-DPDP = mangafodipir trisodium, HDRBC = heat-damaged red blood cell, SI = signal intensityalternative diagnostic tool for IPAS because of its higher
spatial resolution than scintigraphy (7). As the SPIO-based
contrast medium is targeted in the RES cells, it can be used
to demonstrate the presence and function of RES cells
within the lesions. The RES cells show uptake of ferucarbo-
tran and therefore lower SI of the IPASs as well as that of
the main spleen on the T2- or T2*-weighted images (Fig.
7). In addition, the degree of the signal drop in the IPASs is
also similar to that of the spleen. 
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B
Fig. 9. Islet cell tumor in tail of the pancreas. 
A. Arterial phase CT scan (left) reveals well-defined, homoge-
neous, hyperattenuating mass (arrow) in pancreatic tail. Note
zebra-striped enhancement of spleen (S). On delayed phase scan
(right), lesion (arrow) is nearly iso-attenuating compared to
pancreas. 
B, C. Lesion (arrow) is hypointense on T1-weighted gradient echo
image (B) and hyperintense on T2-weighted fat saturated turbo
spin-echo image (C). S: spleen
D. On serial gadolinium-enhanced MR images obtained during
arterial (left upper), pancreatic (right upper), portal (left lower), and
delayed (right lower) phases, lesion conspicuity was most dramatic
on arterial phase and this was diminished on following three
phases. Note homogeneous enhancement of lesion (arrows)
compared to zebra-striped enhancement of spleen (S) on arterial
phase. 
E. On SPIO-enhanced T2-weighted image, no signal drop was
seen in lesion (arrow). Note signal drop of spleen (S) when
compared to precontrast image (C).
CD
E
ATc-99m Heat-damaged Red Blood Cell Scintigraphy
Technetium-99m HDRBC scintigraphy is a highly
specific method for detecting splenic tissue as up to 90% of
the injected HDRBCs are trapped by splenic tissue (15).
The diagnostic criterion used to detect accessory spleen,
including IPAS, was the presence of a marked increase in
uptake that exceeds that of the cardiac blood pool and the
major vessels at the site of suspected accessory spleen (Fig.
8). Autologous HDRBCs are converted into rigid sphero-
cysts; when these are intravenously injected, they are
sequestered by the spleen in the same way that senescent
and damaged cells are handled by the system. Although
Tc-99m HDRBC scintigraphy allows selective splenic
visualization with an excellent spleen-to-liver ratio, splenic
visualization is still difficult under conditions in which
minimal functioning splenic tissue is present, as happens in
cases of accessory spleens. In addition, Tc-99m HDRBC
scintigraphy even with SPECT offers inferior spatial
resolution compared to other cross-sectional imaging
modalities. These problems are more accentuated on
planar imaging than on SPECT. In our study population, a
1.1-cm lesion was missed on Tc-99m SPECT scintigraphy,
but it was detected on CT and MRI. Therefore, SPECT is
frequently used in conjunction with other cross-sectional
imaging modalities to diagnose and precisely localize an
accessory spleen (Fig. 8). 
Kim et al.
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AB
Fig. 10. Solitary pancreatic metastasis from renal cell carcinoma that occurred six years after right nephrectomy. 
A. On arterial phase CT scan (left), lesion (arrows) enhanced more strongly than did spleen (S). Delayed phase CT scan (right) reveals
slightly higher attenuation of lesion (arrows) compared to that of pancreas. 
B. Lesion (arrows) is hypointense and heterogeneous hyperintense compared to pancreas on T1- (left) and T2-weighted (right) MR
images, respectively. 
C. On serial dynamic Gd-enhanced MR images obtained at similar phases to those in Figure 9, metastasis (arrows) demonstrates
enhancement similar to that described on CT. 
D. Precontrast (left) and SPIO-enhanced (right) fat-saturated T2-weighted images do not show any signal drop of lesion (arrows) in
pancreas (arrowheads). Note signal drop of spleen (S) on SPIO-enhanced image (right) when compared to precontrast image (left).
CDDifferentiation from Hypervascular Pancreatic
Neoplasms
Because the imaging findings of IPAS are sometimes
shared with hypervascular pancreatic tumors, knowing the
different imaging characteristics that distinguish between
them is clinically important in order to obviate unneces-
sary surgery or invasive biopsy. The differential points of
the imaging findings of IPAS and hypervascular pancreatic
tumors are summarized in Table 1.
Pancreatic Islet Cell Tumor
Intrapancreatic accessory spleen can be easily differenti-
ated from nonfunctioning islet cell tumor based on the size
of the lesion and the heterogeneity, and the latter is due to
the presence of a necrotic area within the lesion; however,
it may be difficult to differentiate IPAS from functioning
islet cell tumor based on only the imaging findings. 
While IPASs showed hyper-echogenicity compared to
the pancreas and iso-echogenicity compared to the spleen
on all the contrast-enhanced US phases, islet cell tumors
usually become iso- or low-echoic compared to the
pancreas on the portal or delayed phases (16). Therefore,
the prolonged enhancement relative to the pancreas on the
MRI, CT, US and Scintigraphic Findings of Intrapancreatic Accessory Spleen with Pathologic Analysis
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AB
Fig. 11. Epidermoid cyst in intrapancreatic accessory spleen. 
A. Endoscopic US scan shows well-demarcated, low echoic lesion (arrow) attached to pancreatic tail (P) at splenic hilum. Lesion has
several thick septa (arrowheads). 
B. Axial CT images obtained during arterial (left) and portal (right) phases demonstrate cystic mass (arrows) connected to pancreatic tail
(arrowheads). Solid component, which was later revealed to be intrapancreatic accessory spleen, shows same attenuation as spleen (S). 
C. Gross specimen of distal pancreatectomy shows cyst (arrows) in pancreatic tail (P). 
D. On photomicrograph (Hematoxylin & Eosin staining,  40), thin fibrous capsule (F) separates intrapancreatic accessory spleen (AS)
from pancreas (P). On high power field photomicrograph (Hematoxylin & Eosin staining,  100) (right lower corner), cysts (c) are lined by
stratified squamous epithelium. 
CDcontrast-enhanced US provides a clue to the correct differ-
ential diagnosis. The same as for IPAS, the majority of
pancreatic islet cell tumors are hyperattenuating on the
arterial phase CT images (Fig. 9). However, a considerable
proportion (40 45%) of the tumors can be hypo- or
isoattenuating relative to the enhanced pancreas on the
arterial phase CT images (17, 18). Furthermore, islet cell
tumors can have a ring-like enhancement that differs from
the enhancement pattern of IPAS on the arterial phase. In
addition, unlike IPAS, islet cell tumor does not have the
characteristic enhancement pattern, i.e. arciform or zebra-
patterned enhancement, of the spleen and some islet cell
tumors are iso- or low-attenuating compared to the
pancreas on the portal or delayed phase images (12, 13)
(Fig. 9). 
On MRI, islet cell tumors are typically hypointense
compared to the pancreas on the T1-weighted images and
hyperintense on the T2-weighted images, but isointense
T1- and T2-weighted signal intensities have also been
reported (19). The same as on CT, islet cell tumors often
demonstrate uniform or ring-like enhancement and this
may be more conspicuous during the early arterial phase
(Fig. 9). However, a characteristic enhancement pattern,
i.e. arciform or zebra-patterned enhancement, of the
spleen is not shown by islet cell tumor. On SPIO-enhanced
MRI, islet cell tumors do not show negative enhancement
or a loss of signal intensity due to the absence of RES cells
(Fig. 9). 
In addition, Sahani et al. (20) described mangafodipir
trisodium (Mn-DPDP) uptake by a functioning pancreatic
acinar cell carcinoma and they suggested that a functioning
pancreatic tumor should also exhibit the same behavior.
The presence of Mn-DPDP uptake may support the
possibility of a functioning islet cell tumor. 
Hypervascular Metastasis
Hematogenous metastases to the pancreas are rare and
these usually manifest in advanced disease. Melanoma,
lung cancer and breast carcinoma are the most common
origins of pancreatic metastases. The imaging findings of
most pancreatic metastases are similar to those of pancre-
atic adenocarcinoma. However, renal cell carcinoma
metastases may demonstrate a hypervascular appearance
and its imaging findings may mimic those of other
hypervascular pancreatic lesions such as IPAS.
On unenhanced CT studies, pancreatic metastases appear
iso- or hypodense compared to the normal parenchyma.
On contrast-enhanced CT, most hypervascular metastases
avidly enhance during the arterial phase. Nodules smaller
than 1.5 cm in diameter usually have homogeneous
enhancement while large masses are characterized by
heterogeneous enhancement with a central hypodense
area. In these cases, splenic vein involvement may be
observed. Ng et al. (21) reported the CT enhancement
characteristics of renal carcinoma that metastasized to the
pancreas in a series of nine patients. They detected 34
pancreatic metastases that were from 0.6 to 11 cm in
diameter. All the metastases exhibited rapid enhancement
on the arterial phase beginning 25 sec from the start of
injection. The lesion conspicuity was less dramatic on the
60-sec portal phase images and this was diminished even
further on the 120-sec delayed phase images (21) (Fig. 10). 
On MRI, pancreatic lesions appear hypointense
compared to the normal pancreatic parenchyma on the
unenhanced T1-weighted images, both with and without
fat saturation. On T2-weighted images, they have a hetero-
geneous or moderately hyperintense signal (22). If the
lesions are very large, then they can also appear
hypointense. After intravenous gadolinium contrast
administration, a rim of enhancement is visible in the
larger lesions, and homogeneous enhancement is usually
demonstrated in the smaller metastases, as is seen on CT
scans (22) (Fig. 10). On SPIO-enhanced MRI, pancreatic
metastases do not show negative enhancement or loss of
signal intensity because of the absence of RES cells (Fig.
10). Even though making the distinction between renal
cancer pancreatic metastasis and islet cell tumors or IPAS
may be problematic, the clinical history can allow this
distinction to be made. A hypervascular pancreatic tumor
in a patient with a history of renal cell carcinoma should be
considered as metastasis from renal cancer unless proven
otherwise.
Disease of Intrapancreatic Accessory Spleen
Epidermoid Cyst in Intrapancreatic Accessory Spleen
Epidermoid cysts of the spleen are comparatively rare,
accounting for only 10 to 20% of the non-parasitic splenic
cysts (23). Epidermoid cysts are lined with stratified
squamous epithelium, but they have no skin appendages
such as sebaceous glands or sweat glands (Fig. 11).
Furthermore, epidermoid cysts of the accessory spleen are
so rare that only about 10 cases have been reported (6,
24). It is interesting that all the cases of epidermoid cysts of
the accessory spleen have been located in the pancreatic
tail (Fig. 11). Accordingly, the possibility that the epithe-
lium of epidermal cysts of accessory spleen may have
originated from the pancreatic duct has been suggested by
Horibe et al. (25). Those authors also suggested that
frequent recurrence of chronic inflammation and epitheloid
cell granuloma formation in the IPAS may result from an
aberration of the ectopic remaining pancreatic tissue in the
Kim et al.
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The diagnosis of epidermoid cysts of IPAS is quite
difficult and this malady is almost always misdiagnosed as
pancreatic cystic lesions, including pseudocysts, simple
pancreatic cysts, cystic neoplasm and cystic degeneration
of pancreatic tumor such as islet cell tumor and even
adenocarcinoma. There has been only one report in the
English medical literature on the imaging findings of
epidermoid cyst in IPAS (24). In that report, distal pancre-
atectomy and splenectomy were performed and there was
a preoperative diagnosis of cystadenocarcinoma or solid
cystic neoplasm of the pancreas. 
In our case, the solid portion of the lesion showed similar
enhancement to the spleen on both the arterial and portal
CT phases (Fig. 11) even though we also initially missed
the findings. When epidermoid cysts of an accessory spleen
are small and asymptomatic, surgery might not be
necessary. However, in clinical practice, it is safe and
reasonable to perform surgical resection because the
possibility of malignancy cannot be completely excluded.
In general, en-bloc resection of the cyst of the accessory
spleen, including obtaining normal margins of the pancre-
atic tissue, is recommended.
CONCLUSION
Not only the radiologic findings, but also its typical
location may be helpful in arriving at the diagnosis of an
IPAS as it has similar characteristics to those of the spleen
on both the precontrast and contrast-enhanced images of
all imaging modalities. In particular, inhomogeneous
enhancement of an IPAS on the early phases, which is
known to have the characteristic enhancement pattern of
the spleen, may be a diagnostic clue. In addition to Tc-99m
HDRBC scintigraphy, SPIO-enhanced MRI and Levovist-
enhanced US, the mechanisms that are theoretically similar
to that of Tc-99m scintigraphy can be used as an alterna-
tive tool to confirm the diagnosis of IPAS. IPAS shows a
significant signal drop that is similar to the spleen on the
SPIO-enhanced T2 or T2*-weighted image and prolonged
enhancement is seen on the delayed hepatosplenic phase
of contrast-enhanced US. Familiarity with the spectrum of
imaging findings is essential for making the correct diagno-
sis of IPAS. 
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